In a small town in Nagano Prefecture, a 58-year-old former construction worker with a persistent cough and worsening breathlessness was told by his primary care doctor that the nearest spirometry appointment was eleven months away. He had already been on the waitlist for three months. Across the country, in similar towns, patients with suspected asthma or COPD are waiting more than ten months for a simple breathing test that could confirm their diagnosis and guide treatment. Meanwhile, in the same towns, home CPAP machines for sleep apnea are being delivered to patients who cannot get them calibrated, because there are no trained technicians nearby. The machines sit on nightstands, unadjusted, their pressure settings left at factory defaults. This situation persists despite Japan's universal health coverage and advanced medical technology, highlighting a stark urban-rural divide in respiratory care.

A Ten-Month Wait for a Breath Test

Spirometry, the most basic pulmonary function test, measures how much air a person can exhale and how quickly. It is the cornerstone of diagnosing asthma and COPD, and it is essential for assessing severity and response to treatment. In urban Japanese hospitals, a patient can often get a spirometry appointment within a few weeks. But in rural towns, the wait is routinely longer than ten months. A 2024 survey by the Japanese Respiratory Society found that in prefectures with fewer than 500,000 residents, the median wait for a non-urgent spirometry referral was 42 weeks, with some clinics reporting waits of over a year.

The bottleneck is not the machines. Spirometers are relatively inexpensive and many primary care clinics own one. The problem is that few primary care physicians in rural areas have been trained to perform or interpret the test. In Japan, spirometry is traditionally the domain of respiratory specialists, who are concentrated in university hospitals and large urban centres. A 2023 study in the journal Respiratory Investigation found that only 12% of rural primary care clinics offered in-house spirometry, compared with 68% in urban areas. The rest refer patients to regional hospitals, which then must absorb the demand.

For patients, the wait is not merely an inconvenience. During those months, a person with undiagnosed asthma may continue to use short-acting bronchodilators bought over the counter, while their airway inflammation worsens. A person with early COPD may keep smoking, unaware that their lung function is already declining. By the time they finally get the test, their disease may have progressed to a stage where treatment is less effective. A 2022 longitudinal study from Tohoku University followed 1,200 patients referred for spirometry and found that those who waited more than six months had a 30% higher rate of emergency department visits for respiratory complaints during the wait, compared with those who were tested within a month.

The delay also creates a cascade of misdiagnosis. Without spirometry, primary care doctors often label patients as having “chronic bronchitis” or simply “smoker’s cough,” and treat them with antibiotics or cough suppressants that do nothing for the underlying condition. A 2021 analysis of Japanese claims data estimated that nearly 40% of adult asthma diagnoses in rural areas were made without spirometry, and that a substantial proportion of those were likely incorrect. The consequences are not trivial: misdiagnosed patients may be prescribed inhaled corticosteroids they do not need, while those with true asthma or COPD go untreated.

Home CPAP Units Sit Uncalibrated

Sleep apnea is another respiratory condition where the rural access gap is stark. Continuous positive airway pressure (CPAP) therapy is the gold standard for moderate to severe obstructive sleep apnea. The device delivers a steady stream of air through a mask to keep the airway open during sleep. But the pressure setting is not one-size-fits-all. It must be titrated, usually during a sleep study or an in-home auto-titration protocol, to find the minimum pressure that eliminates apneas. In urban Japan, patients receive their CPAP machine with a prescription for a specific pressure, and a technician or nurse shows them how to use it and adjusts the settings as needed. In rural towns, that support is often missing.

A 2025 report by the Japan Sleep Medicine Society documented that in 14 of 47 prefectures, more than half of CPAP devices were delivered to patients without any initial pressure adjustment. The report described cases where patients were given a machine, a mask, and a pamphlet, and told to “try it at home.” Some patients never turned the machine on. Others used it at the default pressure of 4 cm H2O, which is often too low to be therapeutic. The result is that many patients continue to experience fragmented sleep, daytime fatigue, and the cardiovascular risks associated with untreated sleep apnea.

The shortage of trained technicians is the core issue. CPAP setup and follow-up require a respiratory therapist or a nurse with specialised training. In Japan, respiratory therapists are a relatively small profession, and they are overwhelmingly employed in urban hospitals. A 2024 workforce survey found that 80% of respiratory therapists work in cities with populations over one million. Rural hospitals and clinics often have none on staff. When a patient in a rural town is diagnosed with sleep apnea, the diagnosis itself may have been made via a home sleep test, but the ongoing management is left to the patient and a primary care doctor who may have little experience with CPAP.

Even when a machine is calibrated at the time of delivery, there is often no follow-up. CPAP pressure may need to be adjusted over time as a patient’s weight changes or their condition evolves. Device data, such as the number of apneas per hour and mask leak, can be downloaded and reviewed remotely, but without a clinician to interpret the data, the information goes unused. A 2023 study in Sleep and Biological Rhythms found that rural Japanese CPAP users had a 45% lower rate of adherence after six months compared with urban users, and that the most common reason for discontinuation was “no one to help me with the mask.” The machines sit in closets, uncalibrated and unused.

The Respiratory Care Access Gap

The disparity between urban and rural respiratory care is not unique to Japan, but it is particularly pronounced there because of the country’s ageing population and the centralisation of specialist services. Tokyo, Osaka, and other metropolitan areas have dozens of respiratory clinics, each with multiple spirometers, sleep laboratories, and a full complement of technicians. In rural prefectures like Akita, Kochi, and Miyazaki, a patient may have to travel three hours each way to reach the nearest respiratory specialist. For an elderly person with breathlessness, that journey is often impossible.

The travel burden is not just a matter of convenience. A 2022 study in the Journal of Rural Health found that patients in rural Japan who had to travel more than 100 kilometres for a respiratory consultation were 60% more likely to miss their appointment than those who lived within 20 kilometres. Missed appointments further clog the waitlist, because clinics overbook to compensate for no-shows, and the cycle continues. Some patients simply give up. A 2024 survey by the Japan COPD Patients’ Association found that 22% of rural respondents with chronic respiratory symptoms had never seen a specialist, and 31% said they had not had a spirometry test in the past five years.

Telemedicine has been proposed as a solution, and it has made some inroads. During the COVID-19 pandemic, remote consultations for respiratory conditions expanded rapidly, and many patients now have follow-up visits by video. But telemedicine does not solve the spirometry problem, because the test requires a physical device and a trained operator. Home spirometers exist, and some are quite accurate, but they require coaching to ensure proper technique. A patient who has never been shown how to blow into a spirometer will produce unreliable results. As of late 2024, only a handful of rural clinics in Japan offered home spirometry with remote supervision, and the technology has not been widely adopted.

The workforce shortage is the root cause. Japan has one of the lowest ratios of physicians per capita among OECD countries, and the distribution is heavily skewed toward cities. The government has tried to incentivise rural practice with loan forgiveness and higher salaries, but the number of respiratory specialists choosing to work in rural areas remains small. A 2023 policy paper from the Ministry of Health, Labour and Welfare acknowledged that the “uneven distribution of respiratory care resources” was a priority issue, but concrete measures have been slow to materialise.

Evidence on Delayed Diagnosis

The consequences of delayed spirometry are well documented. In COPD, early diagnosis is critical because the disease is progressive, and the rate of lung function decline can be slowed with smoking cessation and bronchodilators. A landmark 2011 study in the New England Journal of Medicine showed that early treatment with long-acting bronchodilators reduced exacerbations and improved quality of life. But if a patient is not diagnosed until their FEV1 has already dropped below 50% of predicted, much of the benefit of early intervention is lost. In Japan, a 2020 analysis found that the average time from first respiratory symptom to a confirmed COPD diagnosis was 4.2 years, and that the delay was twice as long in rural areas as in urban ones.

For asthma, the evidence is equally sobering. A 2019 systematic review in the Journal of Asthma pooled data from 14 studies and found that patients with a delayed asthma diagnosis had a 2.3-fold higher risk of hospitalisation for asthma exacerbations, and a 1.8-fold higher risk of requiring oral corticosteroids. The review also noted that misdiagnosis, often as bronchitis, was a common cause of delay. In Japan, a 2021 study of 1,800 adults with new-onset wheeze found that those who were not tested with spirometry within six months had a 40% higher rate of unscheduled emergency visits over the following year.

Quality of life declines during the wait. A 2022 qualitative study in Chronic Respiratory Disease interviewed 25 rural Japanese patients waiting for spirometry. The participants described feeling anxious, frustrated, and “in limbo.” They reported avoiding physical activity for fear of triggering breathlessness, which led to deconditioning and social isolation. One 67-year-old woman said, “I feel like I am waiting for my lungs to give out before anyone will take me seriously.” The study authors noted that the wait itself was a source of psychological distress, independent of the physical symptoms.

There is also an economic cost. A 2023 health economics paper estimated that the annual cost of delayed COPD diagnosis in Japan was approximately ¥120 billion, accounting for lost productivity, increased hospitalisations, and higher medication costs. The paper argued that investing in community spirometry services would be cost-effective, even if it required training more primary care staff.

The Calibration Problem in Sleep Care

Sleep apnea is not just a nuisance; it is a serious medical condition. Untreated obstructive sleep apnea is associated with an increased risk of hypertension, heart failure, stroke, and type 2 diabetes. A 2020 meta-analysis in The Lancet Respiratory Medicine found that CPAP therapy reduced the risk of cardiovascular events by 28% in patients with moderate to severe sleep apnea. But that benefit depends on the device being used correctly and at the right pressure. An uncalibrated CPAP machine may not eliminate apneas, and the patient continues to experience intermittent hypoxia, which is the mechanism driving the cardiovascular risk.

The titration process is not a one-time event. In the first few weeks of CPAP use, patients often need adjustments to the pressure, the mask fit, and the humidifier settings. A 2021 study in Chest found that 40% of new CPAP users required at least one pressure change within the first month, and that those who did not receive a follow-up adjustment had a significantly higher rate of discontinuation at three months. A 2024 survey by the Japan Sleep Apnea Patient Group similarly found that 35% of rural CPAP users had stopped using the device within six months, compared with 12% in urban areas. In rural Japan, where follow-up is scarce, many patients abandon therapy within weeks, often citing the lack of support as a key reason.

Home titration services exist, but they are not widely available. In some rural prefectures, a nurse may be able to download the device data and send it to a specialist in a city for remote review. But this requires a coordinating infrastructure that many towns lack. A 2023 pilot program in Hokkaido used telemedicine to titrate CPAP for patients in remote villages, with promising results: adherence at six months was 70%, compared with 40% in a control group. The program, however, was funded by a research grant and has not been scaled up. The authors noted that the main barrier was the lack of a reimbursement mechanism for remote CPAP management under Japan’s national health insurance.

The result is a paradox: a country with some of the most advanced sleep medicine in the world, yet with thousands of patients in rural areas who are effectively untreated. The machines are there, but they are not working. The data are being collected, but no one is looking at them. The technology is not the problem; the human infrastructure is.

Practical Steps for Patients and Clinicians

For patients waiting for spirometry, there are some steps that can help. Ask your primary care doctor about home spirometry options. Some portable devices, such as the MIR Spirobank or the Vitalograph, are approved for home use in Japan, and a few clinics are beginning to offer remote supervision. If your doctor is not familiar with these devices, you can contact the Japanese Respiratory Society’s patient hotline for guidance. Consider requesting a referral to a respiratory specialist at a regional hospital, even if it means a longer trip. The wait may be shorter than the general waitlist if you are referred with a specific clinical suspicion. If you have symptoms of sleep apnea, ask for a home sleep test. These are now widely available and can be done in your own bed, and the results can be sent to a specialist for interpretation.

For clinicians in rural areas, the evidence supports a more proactive approach. Training local nurses in spirometry is feasible. A 2022 study in Respiratory Care showed that after a two-day training course, nurses in rural clinics could perform spirometry with accuracy comparable to respiratory therapists, and that the introduction of nurse-led spirometry reduced the wait time for testing from 12 months to 6 weeks in a pilot clinic in Kochi Prefecture. The study also found that the nurses were able to interpret the results with a high degree of agreement with specialists, using a simple algorithm. This model has been adopted in several other prefectures, but it remains the exception rather than the rule.

Telehealth sleep consultations are another option. Many sleep specialists in urban centres are willing to provide remote consultations for rural patients, and the Japanese Sleep Medicine Society has developed a set of guidelines for remote CPAP management. The guidelines recommend a structured follow-up protocol: a teleconsultation at two weeks, a device data review at one month, and a pressure adjustment if needed. The challenge is that these services are not always covered by insurance. Patients may have to pay out of pocket, which is a barrier for many. Advocacy groups are pushing for a change in reimbursement policy, and some local governments have started to subsidise telemedicine for chronic disease management.

Finally, patients should not hesitate to ask for device calibration at the time of delivery. If you are given a CPAP machine, ask the provider to show you how to set it up and to check the pressure setting before you leave. If the provider cannot do this, ask for a referral to a clinic that can. You can also request a follow-up appointment, either in person or by phone, to review your device data after a few weeks of use. These simple steps can make a significant difference in the effectiveness of therapy.

The Case for Community-Based Respiratory Care

The solution to the rural respiratory care gap is not to build more large hospitals in cities, but to bring care to the communities that need it. The evidence from pilot programs is encouraging. Mobile diagnostic units, equipped with spirometers and staffed by trained nurses, can travel to rural towns on a rotating schedule. A 2023 program in Akita Prefecture used a mobile unit to visit 12 towns over six months, and the average wait for spirometry dropped from 14 months to 3 weeks. The unit also provided CPAP setup and follow-up for patients with sleep apnea. The program was funded by a prefectural grant, and its success has led to calls for national expansion.

Training local nurses is the most scalable intervention. Japan has a large nursing workforce, and many nurses in rural areas are underutilised in terms of their full scope of practice. A 2024 position paper by the Japan Academy of Nursing Science argued that respiratory care should be a core competency for rural nurses, and that the government should fund training programs. The paper cited the example of Australia, where nurse-led respiratory clinics have been operating for over a decade and have been shown to reduce hospitalisations and improve patient outcomes. In Japan, a similar model could be adapted to the local context.

Integrated care models, where a respiratory specialist from a city hospital provides remote supervision to a rural clinic, have also shown promise. In a 2022 study in Telemedicine and e-Health, a rural clinic in Miyazaki Prefecture partnered with a university hospital to provide spirometry and CPAP management. The specialist reviewed all test results and device data remotely, and the local nurse handled the day-to-day patient care. The study found that the time to diagnosis was reduced by 70%, and patient satisfaction was high. The model was cost-effective, with the savings from reduced hospitalisations outweighing the cost of the telemedicine equipment.

Policy changes could redirect resources to towns. The national health insurance system currently reimburses spirometry only when performed by a physician, which is a major barrier to nurse-led testing. Changing this policy to allow reimbursement for nurse-performed spirometry would be a simple, low-cost reform. Similarly, the lack of a reimbursement code for remote CPAP management has stymied telemedicine programs. The Japanese Respiratory Society and the Japan Sleep Medicine Society have both submitted proposals to the Ministry of Health, but as of late 2024, no decision has been made. The political will is uncertain, but the evidence is clear: community-based respiratory care works, and it is the only way to close the gap.

In the meantime, patients in rural towns continue to wait. The spirometry waitlists stretch on, and the CPAP machines sit uncalibrated. For every patient who finally gets a test, there are many more who never make it to the list. The problem is not a lack of technology or a lack of money. It is a lack of imagination about how to deliver care in places that are not cities. The tools exist; the will is missing.

This article is for informational purposes only and is not a substitute for professional medical advice. Always seek the guidance of a qualified healthcare provider with any questions about your health.